The company closed its plan on December 29, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,550 KRW | -0.52% | -1.72% | +2.88% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.88% | 122M | |
+20.14% | 43.3B | |
+23.67% | 22.22B | |
+16.89% | 15.43B | |
+23.10% | 14.48B | |
+57.58% | 12.72B | |
-0.05% | 6.79B | |
-10.69% | 6.71B | |
-8.87% | 5.73B | |
+12.71% | 5.5B |
- Stock Market
- Equities
- A023910 Stock
- News Daihan Pharmaceutical Co.,Ltd.
- Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback announced on September 28, 2022, has closed with 120,000 shares, representing 2% for KRW 3,418.04 million.